ID1 and liver cancer: Research on the liver cancer signaling pathway has revealed that bone morphogenetic protein 9 (BMP9) and inhibitor of DNA binding 1 (ID1) can activate the expression of HIF-1α and VEGFA, which affects the angiogenesis of liver cancer lesions (8).